Sartorius Stedim Biotech (SSB) and BD Diagnostics agreed to collaborate on the development, manufacture, and marketing of various ready-to-use, prefilled media products for microbiological applications in pharmaceutical, biotech, and research laboratories.
"BD is known worldwide for its expertise in manufacturing and filling of microbial media. BD's expertise combined with Sartorius Stedim Biotech's know-how in polymeric technologies and applications will help us further extend our expert capabilities in the field of microbiological monitoring," says Dominique Baly, member of the group executive committee at Sartorius.
According to Baly, BD will fill special SSB single-use products with BD culture media and supply these to SSB as prepackaged products. In addition, the companies are exploring options of extending their existing business relationship by pursuing further innovative solutions in the field of microbiological diagnostics," he added.
"The products we plan to develop under our agreement with Sartorius Stedim Biotech will enhance laboratory efficiencies for our pharmaceutical, biotech, and research customers with these unique product offerings," added Bob Ferguson, vp and general manager, BD Diagnostics, diagnostic systems, industrial microbiology. "By combining Sartorius Stedim Biotech's bioprocessing and filtration expertise with BD's microbiological media capabilities, customers will benefit from improved lab productivity and standardization of sample processing."
This article was reprinted from Genetic Engineering & Biotechnology News (GEN) with permission from Mary Ann Liebert, Inc., publishers. Genetic Engineering & Biotechnology News (GEN) has retained its position as the number one biotech publisher around the globe since its launch in 1981. GEN publishes a print edition 21 times a year and has additional exclusive editorial content online, like news and analysis as well as blogs, podcasts, webinars, polls, videos, and application notes. GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.